PGT103 phase I study of Xyotax(TM) [paclitaxel poliglumex] and radiotherapy for locally advanced, unresectable non-small cell lung cancer
Phase of Trial: Phase I
Latest Information Update: 13 Nov 2005
At a glance
- Drugs Paclitaxel poliglumex (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 13 Nov 2005 New trial record.